Thomas A Buchanan
Overview
Explore the profile of Thomas A Buchanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
14401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kahn S, Edelstein S, Arslanian S, Barengolts E, Caprio S, Ehrmann D, et al.
Diabetes Care
. 2021 Jun;
44(9):1948-1960.
PMID: 34135015
Objective: To compare effects of medications and laparoscopic gastric band surgery (LB) on α-cell function in dysglycemic youth and adults in the Restoring Insulin Secretion (RISE) Study protocols. Research Design...
12.
Sam S, Edelstein S, Arslanian S, Barengolts E, Buchanan T, Caprio S, et al.
Diabetes Care
. 2021 Jun;
44(9):1938-1947.
PMID: 34131048
Objective: To identify predictors of glycemic worsening among youth and adults with impaired glucose tolerance (IGT) or recently diagnosed type 2 diabetes in the Restoring Insulin Secretion (RISE) Study. Research...
13.
Kahn S, Mather K, Arslanian S, Barengolts E, Buchanan T, Caprio S, et al.
Diabetes Care
. 2021 Jun;
44(9):1961-1969.
PMID: 34131047
Objective: To determine whether β-cell hyperresponsiveness and insulin resistance in youth versus adults in the Restoring Insulin Secretion (RISE) Study are related to increased glucagon release. Research Design And Methods:...
14.
Chen J, Spracklen C, Marenne G, Varshney A, Corbin L, Luan J, et al.
Nat Genet
. 2021 Jun;
53(6):840-860.
PMID: 34059833
Glycemic traits are used to diagnose and monitor type 2 diabetes and cardiometabolic health. To date, most genetic studies of glycemic traits have focused on individuals of European ancestry. Here...
15.
Xiang A, Martinez M, Trigo E, Utzschneider K, Cree-Green M, Arslanian S, et al.
Obesity (Silver Spring)
. 2021 May;
29(7):1155-1163.
PMID: 34038037
Objective: The aim of this study was to examine the relationship between changes in liver fat and changes in insulin sensitivity and β-cell function 2 years after gastric banding surgery....
16.
Brooks-Worrell B, Tjaden A, Edelstein S, Palomino B, Utzschneider K, Arslanian S, et al.
Front Immunol
. 2021 May;
12:640251.
PMID: 33981301
The presence of islet autoantibodies and islet reactive T cells (T+) in adults with established type 2 diabetes (T2D) have been shown to identify those patients with more severe β-cell...
17.
Dieli-Conwright C, Courneya K, Demark-Wahnefried W, Sami N, Norris M, Fox F, et al.
Sleep
. 2021 Apr;
44(10).
PMID: 33929533
Study Objectives: Poor sleep quality affects nearly one-third of breast cancer survivors and is associated with insulin resistance. The purpose of this secondary analysis was to examine the effects of...
18.
Mather K, Tjaden A, Hoehn A, Nadeau K, Buchanan T, Kahn S, et al.
Am J Physiol Endocrinol Metab
. 2021 Mar;
320(4):E797-E807.
PMID: 33645253
Application of glucose clamp methodologies in multicenter studies brings challenges for standardization. The Restoring Insulin Secretion (RISE) Consortium implemented a hyperglycemic clamp protocol across seven centers using a combination of...
19.
Hannon T, Edelstein S, Arslanian S, Caprio S, Zeitler P, Buchanan T, et al.
Pediatr Diabetes
. 2020 Sep;
21(8):1437-1446.
PMID: 32985775
Background: The RISE Pediatric Medication Study compared strategies for preserving β-cell function, including a 9-month follow-up after treatment withdrawal to test treatment effect durability. Objective: Evaluate OGTT measures of glucose...
20.
Utzschneider K, Tripputi M, Kozedub A, Mather K, Nadeau K, Edelstein S, et al.
Pediatr Diabetes
. 2020 Sep;
21(8):1421-1429.
PMID: 32902875
Objective: Glycemic control deteriorates more rapidly in youth vs adults. We compared model-derived measures of β-cell function between youth and adults with either impaired glucose tolerance (IGT) or type 2...